Pharmaceutical companies want injunctions against patent infringers and oppose compulsory licenses, because with a few high-value patents unshielded infringers would poach and the system would collapse, whereas software companies are more ambivalent and prefer royalties.
factualpending
Speaker
Richard EpsteinEvidence Quote
“they hate compulsory licenses and they love injunctions”
Created: 10/30/2026, 3:22:16 PM
Your notes
Loading notes...